HIGHLIGHTS
- who: Lucia Gandini from the University Queensland, Brisbane, QLD, Australia have published the Article: Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era, in the Journal: (JOURNAL) of July/18,/2022
- how: Three additional studies were identified in citations during full-text screening.
SUMMARY
This result may be attributed to incomplete IL-6 inhibition, allowing a minimal level of signaling to maintain balance in the immune system, given the pleiotropic pro- and anti-inflammatory profile of IL-6. In summary, this . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.